Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,309 | -7,517 | -6,912 | -17,866 | -32,467 |
| Depreciation Amortization | 15 | 66 | 50 | 33 | 163 |
| Accounts receivable | 240 | -192 | 345 | 300 | -313 |
| Accounts payable and accrued liabilities | 672 | -536 | -213 | -2,751 | -2,137 |
| Other Working Capital | 912 | -728 | 132 | -2,451 | -2,450 |
| Other Operating Activity | 2,155 | 3,027 | 461 | 4,234 | 4,312 |
| Operating Cash Flow | $-6,315 | $-5,880 | $-6,137 | $-18,501 | $-32,892 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,375 | -861 | 2,300 | 17,567 | -9,770 |
| PPE Investments | N/A | N/A | N/A | -4 | -11 |
| Purchase Of Investment | N/A | N/A | -1,500 | N/A | 21,243 |
| Other Investing Activity | 0 | -250 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,375 | $-1,111 | $800 | $17,563 | $11,462 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,026 | 8,786 | 6,185 | 70 | 17,368 |
| Financing Cash Flow | $9,026 | $8,786 | $6,185 | $70 | $17,368 |
| Beginning Cash Position | 4,773 | 2,978 | 2,130 | 2,998 | 7,060 |
| End Cash Position | 4,109 | 4,773 | 2,978 | 2,130 | 2,998 |
| Net Cash Flow | $-664 | $1,795 | $848 | $-868 | $-4,062 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,315 | -5,880 | -6,137 | -18,501 | -32,892 |
| Capital Expenditure | N/A | N/A | N/A | -4 | -11 |
| Free Cash Flow | -6,315 | -5,880 | -6,137 | -18,505 | -32,903 |